Circulating B Lymphocytes in Multiple Myeloma Patients Contain an Autocrine IL-6 Driven Pre-Myeloma Cell Population

This publication has 20 references indexed in Scilit:

• Regulation of B Cell Antigen Receptor Signal Transduction and Phosphorylation by CD45
  Science, 1991
• Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia
  American Journal of Hematology, 1991
• Relationship between CD45 antigen expression and putative stages of differentiation in B‐cell malignancies
  American Journal of Hematology, 1991
• Markers of Multiple Hematopoietic-Cell Lineages in Multiple Myeloma
  New England Journal of Medicine, 1990
• Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
  Journal of Clinical Investigation, 1989
• Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
  The Journal of Experimental Medicine, 1989
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988
• Production of hybridoma growth factor by human monocytes
  European Journal of Immunology, 1987
• Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
  Journal of Clinical Investigation, 1985
• Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.
  The Journal of Experimental Medicine, 1979